1、 刘首明,江小萍,沈祖泓,等.可溶性CD40配体和炎症因子水平表达在颈动脉粥样硬化患者的应用[J].现代医院,2021,21(5):803-806. 刘首明,江小萍,沈祖泓,等.可溶性CD40配体和炎症因子水平表达在颈动脉粥样硬化患者的应用[J].现代医院,2021,21(5):803-806.
2、 TONG X K, LECRUX C, ROSA-NETO P, et al. Age-dependent rescue by simvastatin of Alzheimer's disease cerebrovascular and memory deficits[J]. J Neurosci, 2012,32(14):4705-4715. TONG X K, LECRUX C, ROSA-NETO P, et al. Age-dependent rescue by simvastatin of Alzheimer's disease cerebrovascular and memory deficits[J]. J Neurosci, 2012,32(14):4705-4715.
3、 SEGATTO M, MANDUCA A, LECIS C, et al. Simvastatin treatment highlights a new role for the isoprenoid/cholesterol biosynthetic pathway in the modulation of emotional reactivity and cognitive performance in rats[J]. Neuropsychopharmacology, 2014,39(4):841-54. SEGATTO M, MANDUCA A, LECIS C, et al. Simvastatin treatment highlights a new role for the isoprenoid/cholesterol biosynthetic pathway in the modulation of emotional reactivity and cognitive performance in rats[J]. Neuropsychopharmacology, 2014,39(4):841-54.
4、 FRACASSI A, MARANGONI M, ROSSO P, et al. Statins and the brain: more than lipid lowering agents?[J]. Curr Neuropharmacol, 2019,17(1):59-83. FRACASSI A, MARANGONI M, ROSSO P, et al. Statins and the brain: more than lipid lowering agents?[J]. Curr Neuropharmacol, 2019,17(1):59-83.
5、 ZHOU D, LIU H, LI C, et al. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice[J]. Metab Brain Dis,2016,31(3): 693-703. ZHOU D, LIU H, LI C, et al. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice[J]. Metab Brain Dis,2016,31(3): 693-703.
6、 BARTHOLD D, JOYCE G, DIAZ BRINTON R, et al. Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk[J]. PLoS One,2020,15(3): e0229541. BARTHOLD D, JOYCE G, DIAZ BRINTON R, et al. Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk[J]. PLoS One,2020,15(3): e0229541.
7、 MCGUINNESS B, CRAIG D, BULLOCK R, et al. Statins for the prevention of dementia[J]. Cochrane Database Syst Rev, 2016(1):CD003160. MCGUINNESS B, CRAIG D, BULLOCK R, et al. Statins for the prevention of dementia[J]. Cochrane Database Syst Rev, 2016(1):CD003160.
8、 MCGUINNESS B, CRAIG D, BULLOCK R, et al. Statins for the treatment of dementia[J]. Cochrane Database Syst Rev,2014(7): CD007514. MCGUINNESS B, CRAIG D, BULLOCK R, et al. Statins for the treatment of dementia[J]. Cochrane Database Syst Rev,2014(7): CD007514.
9、 贾琳琳. 阿托伐他汀钙片治疗卒中后认知功能障碍患者的综合疗效[J]. 中国药物经济学,2015(12): 73-75. 贾琳琳. 阿托伐他汀钙片治疗卒中后认知功能障碍患者的综合疗效[J]. 中国药物经济学,2015(12): 73-75.
10、 彭富, 黄载文, 梁耀武. 阿托伐他汀对不同阶段血管性认知功能障碍患者血脂和认知功能的影响[J]. 实用临床医药杂志,2016,20(9): 29-31,40. 彭富, 黄载文, 梁耀武. 阿托伐他汀对不同阶段血管性认知功能障碍患者血脂和认知功能的影响[J]. 实用临床医药杂志,2016,20(9): 29-31,40.
11、 任庆国, 梁兵, 孟祥水. 血管性认知障碍临床诊断标准概述[J]. 实用医学杂志,2019,35(1): 1-3. 任庆国, 梁兵, 孟祥水. 血管性认知障碍临床诊断标准概述[J]. 实用医学杂志,2019,35(1): 1-3.
